Microviable Therapeutics SL

Checkout our new GutAlive®!! https://bit.ly/3HCLcUm The unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, microbiota viability and preserves DNA integrity. #gutalive #microbiome #FMT #gutmicrobiota #anaerobes #stoolcollectiondevice #metagenomics

The results presented here show that GutAlive® is the unique device validated for both, microbiome analysis by NGS techniques, and for the isolation of anaerobic microorganisms. GutAlive® can be applied in a wide range of microbiota applications, such as FMT, improving the standardization of protocols and allowing the development of enhanced diagnostic tools and microbiota-based biotherapeutic. More info: https://lnkd.in/dWfEp4_w #microbiome #metagenomics #FMT #microbiota #NGS #sequencing #microbiomekit #anaerobes #anaerobicmicrobiomekit #gutalive

Fecal microbiota transplantation: current challenges and future landscapes https://lnkd.in/dWwNWUT7 ASM Journals Clinical Microbiology Reviews Abbas Yadegar, Haggai Bar-Yoseph, Tanya Monaghan, Sepideh Pakpour Hajiagha, Andrea Severino, Edward Kuijper, Wiep Klaas Smits, Elisabeth Terveer, Sukanya N., Ali Nabavi-Rad, Javad Sadeghi, Giovanni Cammarota, Gianluca Ianiro, Estello Nap Hill, MD, Dickson Leung, Karen Wong, Dina Kao #fecalmicrobiotatransplantation #microbiota #microbiome #FMT

Global compositional and functional states of the human gut microbiome in health and disease. https://lnkd.in/dPrxKUHY GENOME RESEARCH Sunjae Lee, Theo Portlock, Emmanuelle LE CHATELIER, David Moyes, Dusko Ehrlich, Mathias Uhlen, Saeed Shoaie and colleagues The human gut microbiota is of increasing interest, with metagenomics a key tool for analyzing bacterial diversity and functionality in health and disease. Despite increasing efforts to expand microbial gene catalogs and an increasing number of metagenome-assembled genomes, there have been few pan-metagenomic association studies and in-depth functional analyses across different geographies and diseases. Here, the authors explored 6014 human gut metagenome samples across 19 countries and 23 diseases by performing compositional, functional cluster, and integrative analyses. Using interpreted machine learning classification models and statistical methods, we identified Fusobacterium nucleatum and Anaerostipes hadrus with the highest frequencies, enriched and depleted, respectively, across different disease cohorts. Distinct functional distributions were observed in the gut microbiomes of both westernized and nonwesternized populations. These compositional and functional analyses are presented in the open-access Human Gut Microbiome Atlas, allowing for the exploration of the richness, disease, and regional signatures of the gut microbiota across different cohorts. The Human Gut Microbiome Atlas: https://lnkd.in/gcrNARj #microbiome #gutmicrobiome #metagenomics #humangutmicrobiomeatlas #metagenome

Microbiota and Infectious Disease Treatments: A Solution to Antibiotic Resistance. https://lnkd.in/dZbgD8sj Microviable Therapeutics SL In today’s world, antibiotic resistance and multi-resistant bacteria pose a challenge to modern medicine. Innovative therapies involving microbiota and treatments for infectious diseases offer a promising solution to address this issue. The diverse community of microorganisms residing in our intestines has proven to be a key player in the development, prevention, and maintenance of the immune system. Antibiotic resistance has become an increasingly concerning threat to public health. The indiscriminate use of antibiotics in the treatment of infectious diseases has led to some bacteria developing the ability to resist these medications, making infection control more difficult and potentially resulting in serious complications. In this article, the authors will explore how microbiota therapy can combat multi-resistant bacteria. #antibioticresistance #microbiome #infectiousdiseases #microbiotatherapies #multiresistantbacteria

A history of repeated antibiotic usage leads to microbiota-dependent mucus defects. https://lnkd.in/dsziB2NR GUT MICROBES Kertu Liis Krigul, Rachel H. Feeney, Supapit Wongkuna, PhD, Oliver Aasmets, Sandra Holmberg, Reidar Andreson, Fabiola Puértolas Balint, Kateryna Pantiukh 🇺🇦, Linda Sootak, Tonis Org, Tanel Tenson, Elin Org & Bjoern O. Schroeder, PhD #Antibiotics #fecalmicrobiotatransplantation #gutmicrobiome #fattyacids #Akkermansia #microbiome

Non-SCFA microbial metabolites associated with fiber fermentation and host health. https://lnkd.in/dhcwKirU Erica Grant, Hélène De Franco, Mahesh Desai (Luxembourg Institute of Health) #dietaryfiber #fermentation #microbialmetabolites #personalizednutrition

Microbiome and pancreatic cancer: time to think about chemotherapy. https://lnkd.in/dwzUj8Tu GUT MICROBES Juliana de Castilhos, Katharina Tillmanns, Jana Blessing, Arnelyn Doloiras-Laraño, Vadim Borisov, PhD & Christoph Stein-Thoeringer (Hospital of the university of Tübingen) This review synthesizes recent research to provide an in-depth understanding of how the microbiome affects chemotherapy efficacy. It focuses on elucidating key mechanisms and identifying existing knowledge gaps. Addressing these gaps is crucial for enhancing personalized medicine and refining cancer treatment strategies, ultimately improving patient outcomes. #pancreaticductaladenocarcinoma #microbiome #chemotherapy #microbialmetabolism #cancer #pancreaticcancer #microbiomebasedtherapies

Do you know the unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, #microbiota viability and preserves DNA integrity? Checkout our GutAlive® kit!! https://lnkd.in/dWfEp4_w #microbiome #FMT #metagenomic #anaerobes #gutalive #anaerobicmicrobiomekit #stoolcollectiondevice

Microbiota and Infectious Disease Treatments: A Solution to Antibiotic Resistance. https://lnkd.in/dZbgD8sj Microviable Therapeutics SL In today’s world, antibiotic resistance and multi-resistant bacteria pose a challenge to modern medicine. Innovative therapies involving microbiota and treatments for infectious diseases offer a promising solution to address this issue. The diverse community of microorganisms residing in our intestines has proven to be a key player in the development, prevention, and maintenance of the immune system. Antibiotic resistance has become an increasingly concerning threat to public health. The indiscriminate use of antibiotics in the treatment of infectious diseases has led to some bacteria developing the ability to resist these medications, making infection control more difficult and potentially resulting in serious complications. In this article, the authors will explore how microbiota therapy can combat multi-resistant bacteria. #antibioticresistance #microbiome #infectiousdiseases #microbiotatherapies #multiresistantbacteria